AI-generated summary
This review describes the history and general mechanism of intense pulsed light (IPL) and its use for meibomian gland dysfunction (MGD) and dry eye disease (DED). The authors report that several recent clinical studies suggest IPL can improve MGD and DED symptoms and signs. They note that published data on this use are limited and the mechanism remains unclear, so more research is needed.
- Who or what was studied
- Patients with meibomian gland dysfunction and dry eye disease
- Limits stated in the abstract
- The abstract states that published data on IPL for MGD and DED are limited and the mechanism of action remains unclear.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Dry eye. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.